LeapFrog, one of the largest investment firms globally, will be considering to ramp up its exposure to India as it plans to scout for more deals amid the COVID-19 pandemic.
The London-based firm plans on pumping in and allocating around 20% of its $750 million funding that was launched last year, to India.
ET reported (1) that Andrew Kuper, the founder & chief executive of the investment firm that manages the assets worth around $1.5 billion, said that the company would be investing more into Asia’s third-largest economy than what it has done previously.
Kuper said that LeapFrog planned to put more capital into India and increase the amount beyond what previously had been put in by the company. The digital revolution in India has massively accelerated the telcos and played a role in creating a strong entrepreneurial ecosystem.
Highly-accelerated digitization, along with COVID-19 now, has created a vast opportunity to reach out to lower-income people, and the last mile.
Expanding its portfolio across different sectors
The company also appointed Bharat Doshi, the former group CFO & executive director at the Mahindra Group, to its global leadership council.
LeapFrog currently has nine companies in its portfolio that include Ascent Meditech, MedGenome, Dvara, Northern Arc, Fincare, NeoGrowth, and Magma.
The company primarily invests in companies operating in the broader healthcare and fintech sector but is now looking to expand its scope across different sectors.
“LeapFrog, these days, typically invests between $10 million and $70 million in a company, and can also bring in co-investments. Therefore, we could invest well over $100 million. So, we have our net out to catch a good, bright partner.”